我要投票 太一斋在医疗器械行业中的票数:11
· 外 推 电 报 ·
2024-11-23 03:33:21 星期六

【太一斋是哪个国家的品牌?】

太一斋是什么牌子?「太一斋」是 周口太一斋医药科技有限公司 旗下著名品牌。该品牌发源于河南周口,由创始人唐晓光在2017.9.29期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

太一斋,地处伏羲故都,老子故里,有“华夏先驱、九州圣迹”的美誉,被中华全国伏羲文化研究会誉为“中华文化发祥的重地”——周口。

太一斋医药致力于挖掘国药精品,国药、保健以及器械等精优产品,弘扬中医文化,立足大健康行业,服务现代人类,集科研开发,生产销售于一体,实施代理,策划,宣传,售后等完善服务的经营方略。

公司尊重知识,重视人才,以人为本,追求科技创新,积极开拓进取,拥有一支高学厉,高素质,高效率的经营管理服务人员,严谨务实,奋发向上。公司随时与国内各大专院校及科研机构保持着密切的协作关系及联络,致力于推出高品质,高疗效,高标准,低价位的优质产品。

公司自创业以来,便以引导,"创新医药"为己任,以优良的产品,优质的服务,优秀的策划,得到全国各地代理商的一致好评,从而使公司在医药界倍受瞩目,颇有赞誉。

在激烈的市场竞争中,太一斋医药以"创新医药"为导向,独树一帜。我们将一如既往地贯彻"造福人类,回报社会"的经营理念,与您携手再创辉煌。

目前,本公司已为全国各地的众多合作伙伴提供了保姆式的便利与服务。同时,为了实现生产力的低成本扩张,太一斋医药密切关注行业发展动态,对市场资源进行进一步的优化整合,然后采取合作共赢、并购重组等方式进一步扩大公司规模,提高企业竞争力。

太一斋坚持"以人为本"的理念,尊重知识、重视人才,倡导员工和公司的共同发展,崇尚开放式的人才选聘模式。正是这种良好的育人环境,为公司吸引了大批优秀人才。目前为止,太一斋拥有大学本科以上学历的员工已达60%以上,形成了一支具有良好专业水平和熟练技能的优秀团队。

在日益激烈的市场竞争面前,太一斋医药摒弃传统的单一营销模式,结合互联网,创立了一套立体化的新型营销模式。坚持优质客户服务,不断引进国内外优势产品及管理模式。取人之长,补己之短。在不断的自我反思和自我完善中提高自己!

在药品研发方面,太一斋坚持以"安全高效"为导向,在千年国药精髓的基础上,加入现代尖端科学技术,选用上乘药材,精致配伍,做良心药,把患者的健康和利益放在首位。努力把自己打造成患者和经销商的坚强后盾,随时随地为其服务!

太一斋医药将继续秉承"造福人类,回报社会"的经营理念,发扬"与时俱进,开拓创新"的创业精神,充分整合运用自身优势及外部资源,全力将太一斋打造成横跨生物医药、现代中成药、化学合成药以及高科技保健品等多项领域的新型医药品牌。

太一斋相信"福报来源于布施",所以,"造福人类,回报社会"将是太一斋人孜孜不倦的追求!

英文翻译:Taiyizhai, located in Fuxi's hometown, Laozi's hometown, has a good reputation of "Chinese pioneer, Kyushu miracle", and is honored as "the birthplace of Chinese culture" by the all China Fuxi Culture Research Association Zhoukou. Taiyizhai medicine is committed to mining the excellent products of national medicine, national medicine, health care and instruments, carrying forward the culture of traditional Chinese medicine, based on the big health industry, serving modern human beings, integrating scientific research and development, production and sales, implementing the business strategy of agent, planning, publicity, after-sales and other perfect services. The company respects knowledge, attaches great importance to talents, people-oriented, pursues scientific and technological innovation, actively develops and advances, has a highly educated, high-quality and efficient management service personnel, rigorous and pragmatic, and strives to make progress. At any time, the company keeps close cooperation and contact with colleges and universities and scientific research institutions in China, and is committed to promoting high-quality, high curative effect, high standard and low price high-quality products. Since its inception, the company has been guided by the "innovative medicine" as its own responsibility, with excellent products, high-quality services, excellent planning, and has been unanimously praised by agents all over the country, so that the company has attracted much attention in the pharmaceutical industry, and has been highly praised. In the fierce market competition, taiyizhai medicine takes "innovative medicine" as the guidance and develops its own school. We will, as always, implement the business philosophy of "benefiting mankind and returning society", and work with you to create brilliant future. At present, our company has provided nanny convenience and service for many partners all over the country. At the same time, in order to realize the low-cost expansion of productivity, taiyizhai pharmaceutical pays close attention to the development trend of the industry, further optimizes and integrates the market resources, and then further expands the company's scale and improves its competitiveness by means of win-win cooperation, merger and acquisition. Taiyizhai adheres to the concept of "people-oriented", respects knowledge, attaches importance to talents, advocates the common development of employees and the company, and advocates an open talent selection mode. It is this kind of good education environment that attracts a large number of excellent talents for the company. So far, more than 60% of taiyizhai's employees with bachelor's degree or above have formed an excellent team with good professional level and skilled skills. In the face of increasingly fierce market competition, taiyizhai medicine abandoned the traditional single marketing mode, combined with the Internet, created a new three-dimensional marketing mode. Adhere to high-quality customer service, and constantly introduce domestic and foreign superior products and management mode. Learn from others and make up for your own shortcomings. In the aspect of drug research and development, taiyizhai adheres to the guidance of "safety and efficiency", on the basis of the essence of Chinese medicine for thousands of years, adds modern cutting-edge science and technology, selects superior medicinal materials, makes delicate compatibility and conscience medicine, and puts the health and interests of patients first. Strive to build itself into a strong backing for patients and dealers, and serve them anytime and anywhere! Taiyizhai medicine will continue to uphold the business philosophy of "benefiting mankind and returning society", carry forward the entrepreneurial spirit of "advancing with the times and developing innovation", fully integrate its own advantages and external resources, and strive to build taiyizhai into a cross biological medicine, modern Chinese patent medicine and chemical synthetic medicine And high-tech health products and other fields of new pharmaceutical brands. Taiyizhai believes that "blessing comes from giving", so "benefiting human beings and repaying society" will be the tireless pursuit of taiyizhai people!

本文链接: https://www.waitui.com/brand/ef30d5801.html 联系电话:039*****9289 立即查看

千城特选小程序码

7×24h 快讯

三六零:前三季度基于“360智脑”能力开发的互联网ToC端产品直接收入占整体营收不超2%

36氪获悉,三六零发布股票交易异常波动公告,公司于2024年10月31日披露了《三六零安全科技股份有限公司2024年第三季度报告》,2024年1-9月归属于母公司所有者的净利润为-5.79亿元。2024年前三季度,基于“360智脑”能力开发的互联网ToC端产品所产生的直接收入在整体营业收入占比不超过2%,对公司业绩不构成重大影响。

2小时前

小鹏MONA哨兵模式将于明年一季度上线

36氪获悉,小鹏汽车董事长何小鹏在微博发文,小鹏MONA即将于2025年第一季度推出哨兵模式。

2小时前

爱婴室:股东拟减持不超过1%公司股份

36氪获悉,爱婴室发布公告,股东莫锐强的一致行动人茂强投资、莫锐伟拟通过集中竞价交易方式合计减持公司股份不超过138.54万股(即不超过公司总股本的1%)。

2小时前

顺丰控股在香港上市据悉计划将价格定在区间中点

顺丰控股在香港上市据悉计划将价格定在区间中点。(财联社)

2小时前

欧洲央行副行长:降息路径比降息幅度更重要

欧洲央行副行长Luis de Guindos表示,央行显然在降息的道路上,但每次货币政策会议的降息幅度并没有那么重要。他补充说,明年薪资增长将放缓,并且欧洲央行预计通胀将向2%的目标靠拢。“如果我们对明年的通胀预测确实成为现实,那么货币政策路径是明确的,”他周五在马德里的一次会议上说。“我们是降息50个基点还是25个基点的问题就不那么重要了。”(新浪财经)

2小时前

本页详细列出关于诚益通的品牌信息,含品牌所属公司介绍,诚益通所处行业的品牌地位及优势。
咨询